Background : Ischemic Heart Disease (IHD) requires long term treatment which poses huge financial burden.It is very difficult for the patients of developing countries to maintain the treatment costs of IHD. Objectives : To estimate the medical treatment cost and to find out the coping ways of that in Ischemic Heart Disease patients.Methods: A descriptive type of cross sectional study was done during January 2014 to December 2014 at medical out-patient department of National Institute of Cardiovascular Disease (NICVD), Dhaka. Data were collected by using a pre-tested, semi-structured Questionnaire. Medical cost was calculated by drug cost, consultation cost, laboratory investigation cost, surgical cost, hospital cost and food cost. Data analysis was performed by using SPSS software version 20.
Introduction
Ischemic Heart Disease (IHD) is one of the leading cause of death in both developed and developing countries including Bangladesh. 1 It is one of the most common type of heart disease and a major cause of hospital admission. 2 Graduallythe incidence and prevalence of IHD has been increasing in Bangladeshand unless concerned efforts are made and national policy of prevention of risk factors are undertaken, it is feared by next 10-15 years time the number of patients will increase dramatically. 3 The improvement in clinical and interventional cardiology has been progressing at a galloping speed all over the world but it is difficult for our country to transfer that technology due to limited number of specialists in the field and a high cost of technology. The infrastructural development of cardiology both in government and private sectorhas been progressing at a snail's space. 3 that's why treatment of IHDremain still costly. It also contributes major cause of disablement and death. 4 The high cost of IHD has tremendous impact on the patients, especiallyon their families. It is therefore important to understand the coping experience. Coping with the financial hardship become difficult by maximum affected families of our country. For heavy financial load IHD treatment is often discontinued leading to permanent disability and premature death.A significant portion of treatment cost is related to events that require hospital services, specifically inpatient procedures and emergency room visits. The expenditures on inpatient procedures and emergency room visits for all U.S. adults over the age of 55 with IHD exceeded $64.00 billion in 2012. This equates to a mean per person
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expenditure on heart disease related inpatient procedures and emergency room visits of $13,317. 5 But data related to the treatment cost of IHD and the coping ways for that in Bangladesh are often insufficient. Therefore it is necessary to explore themedical treatment cost and its coping ways.Therefore in this cross sectional study we have tried to evaluate the treatment cost and its coping ways.
Methods
A descriptive type of cross sectional study was conducted from January to December 2014 at medical out-patient department of National Institute of Cardiovascular Disease, (NICVD), Dhaka. Non probability purposive sampling technique was used for data collection. Data were collected by face to face interview using a pre-tested, semi-structured Questionnaire and reviewing medical records/documents of the IHD patients. Privacy and confidentiality of respondents were ensured. Questions were prepared in logical sequence as per the variables and specific objectives. The questionnaire was divided into Sociodemographic information of the patient, medical cost and the coping waysof IHD patients.Medical cost was calculated by drug cost, consultation cost, laboratory investigation cost, surgical cost (coronary angiogram, PTCA and bypass surgery), hospital cost and food cost. Coping ways includes source of fund, coping ways in family and socially. Informed consent of the respondents was taken before the interview. Data analysis was performed by using the SPSS software version 20.
Results
Among201 patients, majority (64.7%) were in the age group of 40-59 years and most of them (92.54%) were male. Regarding occupation, 28.8 %were service holder, followed by business 24.9% and unemployed 24.4%. Most of them (56.2%) had monthly family income of Tk. 10001-20000. (Table-I Information related to coping ways for treatment cost of IHD patients. Regarding sources of fund for treatment, majority (37.8%) had taken loanand most (72.6%) of them had changed their life style to cope up with the treatment cost, socially (37.3%) had coped by reducing social contact (Table-IV) . 
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Discussion
Coronary artery disease is highly prevalent in Bangladesh. 6 Moreover Rising prevalence of ischemic heart disease poses huge burden to the individuals and the family. It is a chronic disease and may lead to acute and chronic left ventricular failure and ischemic cardiomyopathy, which requires long term treatment. 7 In our study total 201 IHD patients were included and out of all patients 186 (92.54%) were male and 15 (7.46%) were female. Similarly several studies also showed that IHD was more in males. 8, 9 In this study, average age of the Ischemic Heart Disease patients was 52.37 (± 10.08) years. Most of the patients 130 (64.7%) were within 40-59 years. Several studies found that age is a non-modifiable risk factor for IHD. Men are in high risk of developing coronary heart disease after 45 years and women after 55 years. 10 Among the medical cost, maximum amount of money incurred by the patient for surgical cost Tk. 95783 (±62240) followed by drug cost Tk. 15595 (±7217). This finding is consistent with Liu et.al. who found maximum amount of money needed in hospital inpatient care followed by drug treatment. 5 A study to estimate the economic burden of cardiovascular diseases in the enlarged European Union found inpatient care as maximum proportion of medical care cost followed by medication cost.
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In our study we found that the sources of fund for treatment, majority i.e. 37.8% had taken personal loan for ischemic heart disease treatment, while 24.4% sold their property, 16.9% received donation from friends and relatives followed by 14.4% spend family savings for treatment, 5.0% managed their treatment cost from personal income and only 1.5% patients had health insurance and got the expenses from health insurance. In the developed world, health insurance is a major source of coping for treatment cost. But for the developing countries the coverage of health insurance is very limited. In the present study, maximum number of families took loan from other person on interest.
Conclusion
The study concluded thatthe largest component of medical cost of IHD was the surgical cost which includes coronary angiogram, PTCA and bypass surgery. The patient compensate the burden of medical treatment cost of IHD from family savings, personal income, selling of property, personal loan, donation and health insuranceand by life style change, reduction of food cost, and reducing social contact.
